Literature DB >> 24233795

Phenotypic and genotypic heterogeneity in gaucher disease: Implications for genetic counseling.

E Sidransky1, E I Ginns.   

Abstract

Genetic counseling for Gaucher disease is complicated by the vast degree of clinical heterogeneity encountered in the disorder. Recent advances in our understanding of the molecular genetics of Gaucher disease are particularly relevant to genetic counseling. Although the identification of mutations in the glucocerebrosidase gene has enabled genotypic screening of Gaucher patients, the ability to reliably predict patient outcome on the basis of DNA studies is often limited. An appreciation of both the spectrum of clinical manifestations in Gaucher patients and the limitations of the available genotypic information is necessary when counseling patients, families and at-risk individuals.

Entities:  

Year:  1994        PMID: 24233795     DOI: 10.1007/BF01414603

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  36 in total

1.  High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews.

Authors:  A Zimran; T Gelbart; B Westwood; G A Grabowski; E Beutler
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

Review 2.  Gaucher disease: new molecular approaches to diagnosis and treatment.

Authors:  E Beutler
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

3.  The human glucocerebrosidase gene and pseudogene: structure and evolution.

Authors:  M Horowitz; S Wilder; Z Horowitz; O Reiner; T Gelbart; E Beutler
Journal:  Genomics       Date:  1989-01       Impact factor: 5.736

4.  Clinical heterogeneity among patients with Gaucher's disease.

Authors:  E Sidransky; E I Ginns
Journal:  JAMA       Date:  1993-03-03       Impact factor: 56.272

Review 5.  Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease.

Authors:  G A Grabowski; S Gatt; M Horowitz
Journal:  Crit Rev Biochem Mol Biol       Date:  1990       Impact factor: 8.250

6.  Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.

Authors:  N W Barton; R O Brady; J M Dambrosia; A M Di Bisceglie; S H Doppelt; S C Hill; H J Mankin; G J Murray; R I Parker; C E Argoff
Journal:  N Engl J Med       Date:  1991-05-23       Impact factor: 91.245

7.  Bone-marrow transplantation in severe Gaucher's disease.

Authors:  J M Rappeport; E I Ginns
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

8.  Gaucher disease: gene frequencies in the Ashkenazi Jewish population.

Authors:  E Beutler; N J Nguyen; M W Henneberger; J M Smolec; R A McPherson; C West; T Gelbart
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

9.  Sequence of two alleles responsible for Gaucher disease.

Authors:  C M Hong; T Ohashi; X J Yu; S Weiler; J A Barranger
Journal:  DNA Cell Biol       Date:  1990-05       Impact factor: 3.311

10.  Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications.

Authors:  A Sibille; C M Eng; S J Kim; G Pastores; G A Grabowski
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

View more
  1 in total

1.  Gaucher disease in Syrian children: common mutations identification, and clinical futures.

Authors:  Diana Alasmar
Journal:  Ann Saudi Med       Date:  2015 Mar-Apr       Impact factor: 1.526

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.